Aldehyde Dehydrogenase Serves as a Biomarker for Worse Survival Profiles in Ovarian Cancer Patients: An Updated Meta-Analysis

BMC Women's Health - United Kingdom
doi 10.1186/s12905-018-0686-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

COX-2 Expression in Ovarian Cancer: An Updated Meta-Analysis

Oncotarget
Oncology
2017English

Circular RNA as a Biomarker for Cancer: A Systematic Meta‑analysis

Oncology Letters
Cancer ResearchOncology
2018English

Characterization and Targeting of the Aldehyde Dehydrogenase Subpopulation in Ovarian Cancer

2012English

Meta-Analysis of Gene Expression Profiles Associated With Histological Classification and Survival in 829 Ovarian Cancer Samples

International Journal of Cancer
Cancer ResearchOncology
2011English

CDK1 Serves as a Potential Prognostic Biomarker and Target for Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2020English

Association Between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis

Nutrients
NutritionFood ScienceDietetics
2018English

Neoadjuvant Chemotherapy for Patients With Advanced Epithelial Ovarian Cancer: A Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2005English

Statin Uses and Mortality in Colorectal Cancer Patients: An Updated Systematic Review and Meta‐analysis

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy